ÂÜÀòÂÒÂ×

Adam Asare has a strong background in the healthcare field, particularly in the areas of data analysis and information technology. Adam is currently serving as the Chief Data Officer at QuantumLeap Healthcare Collaborative since January 2017. Prior to that, they were the Director of Information Technology at UCSF Medical Center starting from March 2019.

Adam has also held significant positions at Massachusetts General Hospital, where they served as the Executive Director of Bioinformatics for the Immune Tolerance Network from May 2014 to December 2016. In this role, they managed a team of 12 bioinformatics staff and implemented various analysis techniques for complex datasets. Adam also developed and reviewed data analysis plans for clinical trial protocols.

Prior to that, Adam worked at the University of California, San Francisco (UCSF) where they held the positions of Senior Director of Bioinformatics for the Immune Tolerance Network from February 2011 to April 2014, and Director of Data Analysis for the Immune Tolerance Network from February 2009 to February 2011. During their time at UCSF, Adam established strategic partnerships, initiated outreach programs, and contributed to the development of biomarkers.

Adam's earlier experience includes working as an Associate Director of Data Analysis for the Immune Tolerance Network/UCSF from September 2003 to January 2008, and as a Scientist at Management Sciences Associates from February 2002 to August 2003.

Overall, Adam Asare's work experience demonstrates their expertise in bioinformatics, data analysis, project management, and strategic partnerships in the healthcare industry.

Adam Asare's education history begins in 1985 when they enrolled in the University of Missouri-Kansas City. Adam pursued a combined Bachelor of Arts and Medicine degree program but did not obtain a specific degree. In 1988, they transferred to the University of Missouri-Columbia where they completed a Bachelor's in Journalism degree in 1992. Following this, Adam went on to attend the University of Missouri-Columbia's School of Medicine from 1996 to 2002, where they earned a PhD in Pathobiology and Bioinformatics.